Deferred Income Tax Expense (Benefit) of BIO-TECHNE Corp from 30 Jun 2010 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
BIO-TECHNE Corp annual and quarterly Deferred Income Tax Expense (Benefit) in USD history and change rate from 30 Jun 2010 to 30 Jun 2025.
  • BIO-TECHNE Corp Deferred Income Tax Expense (Benefit) for the quarter ending 30 Sep 2023 was $4,145,000, a 5.7% increase year-over-year.
  • BIO-TECHNE Corp annual Deferred Income Tax Expense (Benefit) for 2025 was $51,152,000, a 27% decline from 2024.
  • BIO-TECHNE Corp annual Deferred Income Tax Expense (Benefit) for 2024 was $40,161,000, a 35% decline from 2023.
  • BIO-TECHNE Corp annual Deferred Income Tax Expense (Benefit) for 2023 was $29,799,000, a 522% decline from 2022.
Source SEC data
View on sec.gov
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Change (%)
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Change (%)

BIO-TECHNE Corp Annual Deferred Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $51,152,000 -$10,991,000 -27% 01 Jul 2024 30 Jun 2025 10-K 22 Aug 2025 2025 FY
2024 $40,161,000 -$10,362,000 -35% 01 Jul 2023 30 Jun 2024 10-K 22 Aug 2025 2025 FY
2023 $29,799,000 -$36,862,000 -522% 01 Jul 2022 30 Jun 2023 10-K 22 Aug 2025 2025 FY
2022 $7,063,000 +$35,076,000 01 Jul 2021 30 Jun 2022 10-K 22 Aug 2024 2024 FY
2021 $28,013,000 -$41,620,000 -306% 01 Jul 2020 30 Jun 2021 10-K 23 Aug 2023 2023 FY
2020 $13,607,000 +$27,628,000 01 Jul 2019 30 Jun 2020 10-K 24 Aug 2022 2022 FY
2019 $14,021,000 +$31,891,000 +69% 01 Jul 2018 30 Jun 2019 10-K 25 Aug 2021 2021 FY
2018 $45,912,000 -$41,062,000 -847% 01 Jul 2017 30 Jun 2018 10-K 26 Aug 2020 2020 FY
2017 $4,850,000 -$2,226,000 -85% 01 Jul 2016 30 Jun 2017 10-K/A 06 Nov 2019 2019 FY
2016 $2,624,000 -$3,928,000 -301% 01 Jul 2015 30 Jun 2016 10-K 27 Aug 2018 2018 FY
2015 $1,304,000 +$4,157,000 01 Jul 2014 30 Jun 2015 10-K 07 Sep 2017 2017 FY
2014 $2,853,000 -$319,000 -13% 01 Jul 2013 30 Jun 2014 10-K 29 Aug 2016 2016 FY
2013 $2,534,000 +$4,829,000 +66% 01 Jul 2012 30 Jun 2013 10-K 31 Aug 2015 2015 FY
2012 $7,363,000 -$10,557,000 -331% 01 Jul 2011 30 Jun 2012 10-K 29 Aug 2014 2014 FY
2011 $3,194,000 +$4,745,000 01 Jul 2010 30 Jun 2011 10-K 29 Aug 2013 2013 FY
2010 $1,551,000 01 Jul 2009 30 Jun 2010 10-K 29 Aug 2012 2012 FY

BIO-TECHNE Corp Quarterly Deferred Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2023 $4,145,000 +$224,000 +5.7% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2023 2024 Q1
Q3 2022 $3,921,000 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023 2024 Q1
Q3 2018 $3,768,000 -$1,584,000 -73% 01 Jul 2018 30 Sep 2018 10-Q 07 Nov 2018 2019 Q1
Q3 2017 $2,184,000 -$1,014,000 -87% 01 Jul 2017 30 Sep 2017 10-Q 07 Nov 2018 2019 Q1
Q3 2016 $1,170,000 -$55,000 -4.9% 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2016 2017 Q1
Q3 2015 $1,115,000 +$502,000 +31% 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2016 2017 Q1
Q3 2014 $1,617,000 -$288,000 -22% 01 Jul 2014 30 Sep 2014 10-Q 09 Nov 2015 2016 Q1
Q3 2013 $1,329,000 -$552,000 -71% 01 Jul 2013 30 Sep 2013 10-Q 10 Nov 2014 2015 Q1
Q3 2012 $777,000 +$289,000 +27% 01 Jul 2012 30 Sep 2012 10-Q 12 Nov 2013 2014 Q1
Q3 2011 $1,066,000 -$1,877,000 -231% 01 Jul 2011 30 Sep 2011 10-Q 09 Nov 2012 2013 Q1
Q3 2010 $811,000 01 Jul 2010 30 Sep 2010 10-Q 09 Nov 2011 2012 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.